Silicon Laboratories (SLAB) Cash & Equivalents (2009 - 2026)

Silicon Laboratories (SLAB) has reported Cash & Equivalents for 18 consecutive years, with $383.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Equivalents rose 17.92% year-over-year to $383.1 million; the TTM figure through Apr 2026 stood at $383.1 million (up 17.92% YoY), while the FY2026 annual figure was $364.2 million, up 29.34% from the prior year.
• Cash & Equivalents came in at $383.1 million for Q2 2026 at Silicon Laboratories, up from $364.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.1 billion in Q1 2022, with the low at $159.9 million in Q3 2023.
• Average Cash & Equivalents over 5 years is $411.8 million, with a median of $333.1 million recorded in 2025.
• Across the five-year window, Cash & Equivalents jumped 430.1% in 2022 and plunged 73.27% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $499.9 million in 2022, then slumped by 54.49% to $227.5 million in 2023, then climbed by 23.78% to $281.6 million in 2024, then gained by 21.23% to $341.4 million in 2025, then gained by 12.21% to $383.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $383.1 million, $364.2 million, and $341.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.